Eli Lilly said Wednesday it will invest $27 billion to build four new manufacturing plants in the United States as the pharmaceutical giant grapples with the threat of drug import duties from the ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

Members of the Lebanon Plan Commission will review designs next week for Eli Lilly and Co.’s $4.5 billion center for advanced manufacturing and drug development at the LEAP Research and ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options ... Move Benzinga Edge's Unusual Options board spots potential market movers before ...